Abivax upgraded to Buy from Hold at Jefferies
bullish
Public signal · 1-minute delayed
Source-backed market context you can read and share without an account.
bullish
What happened, with direct paths to the underlying reporting
Jefferies upgrades ABVX to Buy; target 158; current price 133.26; suggests upside.
Target: $158
Posted price: $133.26
Analyst firm: Jefferies
Analyst: Faisal Khurshid
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.